Back to 
FIRST MANHATTAN CO. LLC.
FIRST MANHATTAN CO. LLC.
CYTK
Showing 0 of 2 quarters
Position history for FIRST MANHATTAN CO. LLC.'s holdings in CYTOKINETICS INC
No. First Manhattan exited its CYTK (Cytokinetics) position in Q2 2019. Its Q1 2019 13F listed 18,288 shares worth $147,000. First Manhattan first reported CYTK in Q1 2019 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.